韦莱韬悦
WTW
315.49
+5.13
+1.65%
韦莱韬悦
US · WTW
#736 按市值排名
上市于 1970
315.49
+5.13
+1.65%
实时 - 追踪5344个代码 - 心跳于39秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 101.36% +0.08pp
- 机构数量
- 872 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund91.78%
Hedge Fund2.35%
Public Company2.08%
Government Pension Fund1.71%
Sovereign Wealth Fund1.60%
Private Company1.14%
Individual/Insider0.36%
Insurance Company0.27%
VC/PE Fund0.12%
主要股东 截至 2026-06-30
BlackRock
8.95% · 8.31M 股
Dodge & Cox
8.64% · 8.03M 股
Vanguard Capital Management, LLC
7.22% · 6.70M 股
Harris Associates L.P.
6.36% · 5.91M 股
Artisan Partners Limited Partnership
5.97% · 5.54M 股
MFS Investment Management
5.91% · 5.49M 股
First Eagle Investment Management, LLC
4.82% · 4.48M 股
State Street Global Advisors
4.65% · 4.32M 股
Vanguard Portfolio Management, LLC
4.38% · 4.06M 股
Geode Capital Management, LLC
2.80% · 2.60M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 39次买入 · 10次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Carl Hess | Chief Executive Officer | 0.11% |
| Julie Gebauer | Global Head of Health, Wealth & Career | 0.08% |
| Matthew Furman | General Counsel | 0.04% |
| Andrew Krasner | Chief Financial Officer | 0.03% |
| Anne Pullum | Head of Europe | 0.02% |
| Paul Thomas | Independent Non-Executive Chair of the Board | 0.01% |
| Lucy Clarke | President of Risk & Broking | 0.01% |
| Kristy Banas | Chief Human Resources Officer | 0.01% |
| Alexis Faber | Chief Operating Officer | 0.01% |
| Imran Qureshi | MD & Head of North America | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Lucy Clarke | President of Risk & Broking | Sale to Issuer | -1,916 | $288.23 |
| 2026-08-12 | Carl Hess | Chief Executive Officer | Other Derivative Acquisition | +53 | -- |
| 2026-08-12 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Derivative Acquisition | +12 | -- |
| 2026-08-12 | Andrew Krasner | Chief Financial Officer | Other Derivative Acquisition | +4 | -- |
| 2026-08-09 | Alexis Faber | Chief Operating Officer | Open Market Disposition | -730 | $342.70 |
| 2026-07-14 | Carl Hess | Chief Executive Officer | Other Acquisition | +51 | -- |
| 2026-07-14 | Carl Hess | Chief Executive Officer | Other Derivative Acquisition | +63 | -- |
| 2026-07-14 | Matthew Furman | General Counsel | Other Acquisition | +6 | -- |
| 2026-07-14 | Matthew Furman | General Counsel | Other Derivative Acquisition | +20 | -- |
| 2026-07-14 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Acquisition | +11 | -- |
| 2026-07-14 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Derivative Acquisition | +101 | -- |
| 2026-07-14 | Anne Pullum | Head of Europe | Other Acquisition | +6 | -- |
| 2026-07-14 | Anne Pullum | Head of Europe | Other Derivative Acquisition | +11 | -- |
| 2026-07-14 | Imran Qureshi | MD & Head of North America | Other Acquisition | +6 | -- |
| 2026-07-14 | Imran Qureshi | MD & Head of North America | Other Derivative Acquisition | +16 | -- |
| 2026-07-14 | Alexis Faber | Chief Operating Officer | Other Acquisition | +5 | -- |
| 2026-07-14 | Alexis Faber | Chief Operating Officer | Other Derivative Acquisition | +12 | -- |
| 2026-07-14 | Andrew Krasner | Chief Financial Officer | Other Acquisition | +15 | -- |
| 2026-07-14 | Andrew Krasner | Chief Financial Officer | Other Derivative Acquisition | +11 | -- |
| 2026-07-14 | Lucy Clarke | President of Risk & Broking | Other Acquisition | +41 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
韦莱韬悦 讨论区 0 条评论